• AAPL 165
  • TSLA 147.05
  • AMZN 174.63
  • MSFT 399.12
  • INTC 34.2
  • EURUSD 1.0661
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. BA /
  3. MOLI.BA

Molinos Rio de la Plata SA (MOLI BA) stock market data APIs

ARS3131 -56(-1.8%) as of April 19, 2024

Molinos Rio de la Plata SA Financial Data Overview

3187
3131
-
3209
3050
489.9304-5550
643 176 M
13.6055
201 M
432 856 M
14.4039
0.0141
0.916
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'MOLI',
Type: 'Common Stock',
Name: 'Molinos Rio de la Plata SA',
Exchange: 'BA',
CurrencyCode: 'ARS',
CurrencyName: 'Argentine Peso',
CurrencySymbol: 'ARS',
CountryName: 'Argentina',
CountryISO: 'AR',
OpenFigi: NULL,
ISIN: 'ARP689251337',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Consumer Defensive',
Industry: 'Packaged Foods',
}

Molinos Rio de la Plata SA Fundamental Data is available in our Financial Data APIs

  • Net Revenue 432 856 M
  • EBITDA 50 013 M
  • Earnings Per Share 229.43
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Molinos Rio de la Plata SA Earnings via APIs

  • Latest Release 2023-05-10
  • EPS/Forecast NaN

Get Molinos Rio de la Plata SA End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Molinos Rio de la Plata SA latest news via APIs

Cyclo Therapeutics Receives Positive Opinion from the Paediatric Committee of the European Medicines Agency on the Agreement of a Paediatric Investigation Plan for Trappsol® Cyclo™

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation f...
  • BIOTECHNOLOGY COMPANY
  • DEVELOPMENT
  • EUROPE
  • EUROPEAN MEDICINES AGENCY
  • EUROPEAN UNION
  • PAEDIATRIC COMMITTEE
  • PAEDIATRIC INVESTIGATION PLAN
  • REGULATORY AUTHORITIES
  • THERAPEUTICS

Cyclo Therapeutics Receives Positive Opinion from the Paediatric Committee of the European Medicines Agency on the Agreement of a Paediatric Investigation Plan for Trappsol® Cyclo™

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation f...
  • BIOTECHNOLOGY COMPANY
  • DEVELOPMENT
  • EUROPE
  • EUROPEAN MEDICINES AGENCY
  • EUROPEAN UNION
  • PAEDIATRIC COMMITTEE
  • PAEDIATRIC INVESTIGATION PLAN
  • REGULATORY AUTHORITIES
  • THERAPEUTICS
Do you have any questions?
support@eodhistoricaldata.com